Journal of Advanced Biotechnology and Experimental Therapeutics
01. A correspondent is recommended to be a submitter. In some cases, the representative correspondent might be the submitter.
02. Authors instructions should be read carefully before preparing the manuscript
03. Provided abstract meets specified word numbers (not exceeding 250 and 150 words for Original Article and Review Article/Short Communication/Case Report, respectively)
04. The cover letter should be prepared (should be inserted on the submission step).
05. Title page and the rest of the manuscript text should be prepared in the same file. Figure legends, Table and figure files could be inserted at the end of the same file
06. Font of the main text should be Times New Roman of 12 pt size, double-spaced.
07. Maximum of 3-6 Keywords should be provided.
08. At least two potential reviewers should be given with official address and e-mail.
09. Ethical approval number and statement should be put in the MATERIALS AND METHODS section
10. Plagiarism should be checked and found below 20% (excluding reference section)
11. Page and line numbers should be inserted in the manuscript.
12. Schematic diagram of summary or abstract is highly recommended for original/review articles
13. References should be arranged as per JABET rules (check once).
JABET allows submissions online at https://www.ejmanager.com/my/jabet/. All authors should read and apply the instructions, including specifications of file types for text and illustrations given on the site. Should authors encounter difficulties they may contact editorial office at firstname.lastname@example.org or email@example.com or Phone: +821086737008.
Aims and Scope
JABET is a peer-reviewed journal devoted to publishing the latest developments in translational research and the recent discoveries in the field of Biotechnology and Biomedical Sciences. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human, animal, environment, and plant subjects. Papers should provide rigorous quantitative analyses and/or new insights on biochemical mechanisms.
Topics of particular interest within the journal’s scope include, but are not limited to, those listed below:
Cellular and Molecular Biology
Genetics and Genomics
Immunology and Physiology
Inflammation and Immunity
Metabolism and Diseases
Microbiology and Infection
Nano-Bioscience and Bioinformatics
Pharmacology and Toxicology
Plant Biology and Herbal Medicine
Reproductive and Aquatic Biology
Stem Cells and Cancer Biology
Major type of articles:
1. Original article
2. Review article
3. Short communication
4. Editorial/ Letter to the editor
5. Case report
Cover letter: The “cover letter” should include message to the Editor-in-Chief, Title of the manuscript, names of all authors with their affiliations and contact details including Email addresses, and details of the corresponding author.
Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere. This must be stated in the covering letter. Authors must declare any financial support or relationships that may pose the conflict of interest. If tables or figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter. In case of revised manuscripts submission, point-by-point response of reviewer’s or editorial’s comments should be attached.
Organization of main article file: Line and page numbers should be inserted starting from the beginning. Text should be double-spaced, and font to be New Times Roman (size-12). Manuscripts should be presented in the following order (omitting sections inappropriate for specific article types e.g. Methods for Reviews): (i) Title page, (ii) Abstract and Keywords, (iii) Introduction, (iv) Materials and Methods, (v) Results, (vi) Discussion, (vii) Acknowledgements>Conflicts of interest>Authors contribution, (viii) References, (ix) Figure legends, (x) Tables (each table complete with title and footnotes), and (xi) Supplementary methods & materials, figure legends, and tables (if any). Figure files could be inserted at the end of the main article file or separately in submission system. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter. In some case, (v) and (vi) can be written together. Schematic diagram of summary or abstract is highly recommended for original/review articles.
1. Original article
Title page: The title page should contain (i) the title of the paper, (ii) the full names of the authors and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and email address, plus facsimile and telephone numbers of the author to whom correspondence about the manuscript should be sent. The title should be short (fewer than 100 characters) and informative, and contain the major keywords. The submitted manuscript or its essential content must not have been published previously or be under consideration for publication elsewhere. This page could be merged with Abstracts and Keywords as per sample main article provided above.
Abstract: The abstract should be brief not exceeding 250 words. The purposes of an abstract are to give a clear indication of the objective, scope, and results of the paper so that readers may determine whether the full text will be of particular interest to them. Order should be- Objective > Materials and methods > Results > Conclusion (paragraph for each category is not required). The abstract of review may not be subdivided into the order mentioned above.
Keywords: Each paper should have 3-6 keywords indicating the contents of manuscripts. The keywords are used for indexing, abstracting, and retrieval purposes.
Introduction: The introductory section should contain a brief review of the problem with which the study deals, validate the approach taken, and clearly formulate the goals.It is recommended to use present indefinite verb tense.
Materials and Methods: This section comprises a full description of the object of the study (including Latin names), The original names of instruments and reagents should be specified, and the manufacturer’s name (company, country) should be given in parentheses. Please indicate the source from which the sample has been obtained.
Results: Results should be illustrated by tables and figures (which should not duplicate each other). Rather than mechanically repeating the data of tables and graphs, the text should seek to reveal the principles detected. It is recommended to use past indefinite verb tense in describing the results.
Discussion: This section should provide a concise description of experimental data obtained. Rather than mechanically repeating the data of tables and graphs, the text should seek to reveal the principles detected. It is recommended to use present indefinite verb tense in describing the results. The discussion should not reiterate the results.
Conclusion: This section should be completed with a major conclusion that answers the question specified in the introductory part of the article.
Acknowledgment: The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate. (It will be assumed that the absence of such an acknowledgment is a statement by the authors that no support was received.)
Reference: At least 40% references should be taken from the recent years (last five years). References older than the year 2000 should be avoided. The references should be numbered in the order in which they appear in the text in bracket eg. , [2, 3], [4-8]. References to published abstracts should be mentioned in the text but not in the reference list.
In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first six followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2007, unpubl. data). All citations mentioned in the text, tables or figures must be listed in the reference list. For reference, please use Mendeley Desktop reference style of Theriogenology. How to work on Mendeley, please see the video. Names of journals should be abbreviated in the style used in PubMed. Addition of DOI number is preferred.
Authors are responsible for the accuracy of the references.
 Voskoboinik I, Trapani JA. Addressing the mysteries of perforin function. Immunol Cell Biol. 2006; 84: 66-71.
Journal article – no pagination
 Jelinic P, Stehle JC, Shaw P. The testis-specific factor CTCFL cooperates with the protein
methyltransferase PRMT7 in H19 imprinting control region methylation. PLoS Biol 2006; 4: e355. doi:10.1371/journal.pbio.0040355.
Journal article – in press
 Davis ID, Chen Q, Morris L, Quirk J, Stanley M, Tavarnesi ML et al. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients. J Immunother (in press).
Journal article – e-pub ahead of print
 Liston A, Siggs O, Goodnow CC. Tracing the action of IL-2 in tolerance to islet-specific antigen. Immunol Cell Biol 2007; e-pub ahead of print 20 March 2007; doi:10.1038/sj.icb.7100049.
 Peltz G. Computational Genetics and Genomics: Tools for Understanding Disease. Humana Press: Totowa, NJ, USA, 2005.
Chapter in a Book
 Durham SR. Eosinophils and bronchial hyper-responsiveness in bronchial asthma. In: Kay AB (ed). Eosinophils, Allergy and Asthma. Blackwell Science: Oxford, UK, 1990, pp 140–43.
Figure legends: Figures and images should be labelled sequentially, numbered and cited in the text. Each panel in the figure should be labeled in lower case letters. Figure legends should be brief, specific and appear on a separate manuscript page after the References section. Refer to (and cite) figures specifically in the text of the paper. Figures should not be embedded within the text.
Tables: Tables should be typed as text, using either ‘tabs’ or a table editor for layout. Do not use graphics software to create tables. These should be labeled sequentially as Table 1, Table 2, etc. Each table should be numbered and titled, and cited in the text. Reference to table footnotes should be made by means of Arabic numerals. Tables should not duplicate the content of the text. They should consist of at least two columns; columns should always have headings. Authors should ensure that the data in the tables are consistent with those cited in the relevant places in the text, totals add up correctly, and percentages have been calculated correctly. Unlike figures or images, tables may be embedded into the word processing software if necessary, or supplied as separate electronic files.
Figures or Graphs: Please make the illustrations using an acceptable format: TIFF or JPEG (resolution independent files). If accepted, authors will be asked to send us illustrator (EPS) file or PPT file. If a table or figure has been published before, the authors must obtain written permission to reproduce the material in both print and electronic formats from the copyright owner and submit it with the manuscript. This follows for quotes, illustrations and other materials taken from previously published works not in the public domain. The original source should be cited in the figure caption or table footnote.
Each figure legend should have a brief title that describes the entire figure without citing specific panels, followed by a description of each panel. For any figures presenting pooled data, the measures should be defined in the figure legends (for example, data are represented as mean +/- SEM).
Supplementary information: Supplementary information such as figures to be uploaded as the image file (make the illustrations using an acceptable format: TIFF or JPEG). Supplementary methods & materials, figure legends or tables to be at the end of the main manuscript file. Any others file format (videos, etc) to be sent through email: firstname.lastname@example.org.
2. Review paper
Abstract should include objectives, and main focusing points described in the paper. Illustration of the contents using table, figures, sketch is preferable. Should cite at least 50 references, most of which should be of recent ones. [Note: Mini-Review could be written in this style].
3. Short communication
These are short reports of original research focused on an outstanding finding whose importance means that it will be of interest to scientists in other fields.It does not normally exceed 3 pages and allow up to 30 references. These typically have 2 or 3 small display items (figures or tables). It begins with a fully referenced paragraph, ideally of about 150 words, but certainly no more than 250 words, aimed at readers in other disciplines. This paragraph starts with a 2-3 sentence basic introduction to the field; followed by a one-sentence statement of the main conclusions starting; and finally, 2-3 sentences putting the main findings into general context so it is clear how the results described in the paper have moved the field forwards. The rest of the text is typically about 1,200 words long. Any discussion at the end of the text should be as succinct as possible, not repeating previous summary/introduction material, to briefly convey the general relevance of the work. These typically have 2 or 3 small display items (figures or tables).
4. Editorial/ Letter to the editor
This section could be formatted as described in Short communication.
5. Case Report
It should contain- abstract > keywords > case history > clinical examination > treatment/surgery/management > discussion > conclusion > acknowledgement (if any) > conflict of interest > references.
Abbreviations, Symbols and Nomenclature
👉 Abbreviations of chemical, biological, medical or other terms should be used if that is accepted internationally. All specifications must be stated according to the S.I. system. Concentrations of chemical solutions are to be given in mol/L. All other concentrations should be given in % (volume or weight).
👉 The full name must be stated in brackets when the abbreviation is first used.
👉 Some abbreviations: Hours >> h, Minutes >> min, grams >> g
👉 All biological, medical, chemical or other terms should be used according to the most recent recommendations of the respective international nomenclature.
👉 Enzymes should be given in I.U. (International Units), according to Enzyme Nomenclature (Elsevier Publishing Co., 1965).
👉 In the case of commercially obtained substances or reagents, when they are first mentioned in the text, the name and address of the manufacturer or supplier should be given as a footnote.
👉 Products (preparations etc.) with a registered trademark should be marked with.
👉 Bacterial names should be in accordance with the latest edition of Bergey’s Manual of Determinative Bacteriology (The Williams and Wilkins Co., Baltimore).
👉 Viruses are to be given the classification and names recommended by the International Committee on the Nomenclature of Viruses.
👉 Names of micro-organisms and zoological names should be in italics in the manuscript.
Peer Review Policy
After the manuscript is received, it is primarily checked by the Editor-in-Chief. a) If the manuscript is not well formatted, it is sent back to the corresponding author. b) If the content is not satisfactory or does not match the scopes of JABET, the manuscript is sent back as rejected instantly. c) Upon passing the preliminary screening, the manuscript is sent to at least two expert peer reviewers.
An invitation for each reviewer is sent by e-mail from the journal management system. Only the title and abstract of the manuscript are included in the e-mail invitation. After accepting the invitation, the reviewer gets full access to the entire manuscript (at least 3 weeks are allowed). Information about the reviewers are kept confidential (closed).
After the completion of the peer-review process, the revised manuscript is sent to the section /associate editor for critical checking and seeking the primary comments whether the manuscript can be accepted or it is sent for revision. The revision time allowed for individual manuscript may vary depending on the extent of work as suggested by the reviewers. A final decision on a manuscript is finally made by the Editor-in-Chief considering the comments of the expert reviewers and the section editor.
The decision may be any one of the following:
Accept (with or without editorial revision)
Suggest the authors for more revision (at least 4 weeks)
Reject, typically on grounds of specialist interest, lack of novelty, insufficient conceptual advance or major technical and/or interpretational problem.
Approximately, the time from receipt to acceptance of the manuscript is 8-10 weeks.
The whole the submission, peer-review, and editorial processes are maintained through the journal management system.
After provisional acceptance, the corresponding author is notified about the acceptance and is requested to complete the payment process. The corresponding author is given two weeks of time for the completion of payment, and the author must be completed the process within this time frame. Upon receiving the payment, English language editing is done by experts. Then, the manuscript is formatted to make galley proof. The galley proof is sent as PDF file to the corresponding author, and 5 days is given for the corrections by the authors. Once the corrections are effected in the galley, the article is sent to the Editor-in-Chief for final quality control step. Once the quality control step is completed, a DOI is assigned. Then the article is published as LATEST ARTICLES or ONLINE version.
After the publication of the ONLINE version, minor corrections (careless mistakes) noticed by the author can be corrected within 3 days. However, the title, author list, and their affiliations is not be changed. Then the version is considered as complete and final, the final version is included in the upcoming issue with volume and page numbers. Please note that the author is responsible for all statements made in their work, including changes made.
The corresponding author must declare in the cover letter that the manuscript has not submitted to any journal for possible publication, or has not published elsewhere (in part or full). If we notice such kind of malpractice, the author(s) will be blacklisted for our journal, and no article from those authors will be processed in future. Besides, the list of authors may be forwarded to the editors of other related journals around the world. See the COPE guidelines.
Retraction: Click Here
Upon submitting an article, authors should be agreed to abide by an open-access Creative Commons license. Under the terms of this license, authors retain ownership of the copyright of their articles. However, the license permits any user to download, print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work. The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Ethics of publication and experimentation
JABET follows the rules and regulations set by ICMJE (The International Committee of Medical Journal Editors). So, the authors are requested to prepare their manuscripts accordingly.
Authorship: According to the ICMJE, authorship criteria should be based on- 1) substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published. Authors should meet conditions 1, 2 and 3.
Before submission, all authors must read and approve the final version of the manuscript. All named authors must have made an active contribution to the conception and design and/or analysis and interpretation of the data and/or the drafting of the paper.It is a requirement that all authors have been accredited as appropriate upon submission of the manuscript. Contributors who do not qualify as authors should be mentioned under Acknowledgements.
Change in authorship: We do not allow any change in authorship after provisional acceptance. We cannot allow any addition, deletion or change in sequence of author name. We have this policy to prevent the fraud.
Acknowledgements: Under Acknowledgements please specify contributors to the article other than the authors accredited. Please also include specifications of the source of funding for the study and any potential conflict of interests if appropriate. Suppliers of materials should be named and their location (town, state/county, country) included.
Plagiarism: All submissions to JABET are screened by iThenticate, a professional plagiarism checker. Manuscripts that are found to have been plagiarized by authors, whether published or unpublished, will not be accepted for publications. To reduce the similarity, please give proper citations and use the words/sentences carefully.
Conflict of interests: The author must declare any conflict of interests in the relation of financial benefits or others.
Ethical approvals for animal experimentation: Experimental Subjects: When experimental animals (All live animals considered experimental when using for the study) are used, the methods section must clearly indicate that adequate measures were taken to minimize pain or discomfort. Experiments should be carried out in accordance with the Guidelines laid down by the International Animal Ethics Committee or Institutional ethics committee and in accordance with local laws and regulations. All studies using human or animal subjects should include an explicit statement in the Material and Methods section identifying the review and ethics committee approval for each study, if applicable. Editors reserve the right to reject papers if there is doubt as to whether appropriate procedures have been used.
Permission: If all or parts of previously published illustrations are used, permission must be obtained from the copyright holder concerned. It is the author’s responsibility to obtain these in writing and provide copies to the Publishers.
Fees and Payments
JABET does not need any submission charges.
Article processing charges (used as Journal’s maintenance cost only).
JABET is a self-supporting journal and does not have funding from any institution/government. Hence, the management of the journal has to be solely financed by the article processing charges received from authors / their academics / donors. The article processing charges are requested to meet maintenance of different expenses such as website, hosting, domain, application development, support services, DOI, plagiarism checking, ejmanager (online submission, review, and editorial system), SEO services, typesetting of article’s PDF, and so on. Thus, authors are requested to pay a fair article processing charges only for their accepted articles. When an article is accepted, processed, reviewed and authorized for publication, further payment instructions are provided to the corresponding author through e-mail. Charges are to be paid within 7 days as per instructions given in the e-mail.
📣NOTE: If you face any difficulty to make payment or if you want to pay through other ways, please send us an e-mail to email@example.com or firstname.lastname@example.org. We will respond to you with further instructions on how to proceed with a payment by bank transfer or any other means for payment of the article processing charges. *In addition, in case of any offer or announcement posted in the journal’s homepage or special circumstances are found, this payment can be ignored or optimized accordingly.
Articles of JABET are under the terms of Creative Commons Attribution License (CC-BY-NC).